Clinical Trial Update: [18F]-rhPSMA PET-CT Imaging Performance in Patients With Prostate Cancer [NA]

View source ↗

Summary

Clinical trial update evaluating the imaging performance of the fluorine-18 labeled rhPSMA PET-CT tracer in patients with prostate cancer; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• [18F]-rhPSMA PET-CT (rhPSMA radiotracer (fluorine-18 labeled PSMA ligand))

Snippet

Sponsor: City of Hope Medical Center | Conditions: Prostate Carcinoma | NA | Status: RECRUITING